Item 2.02 Results of Operations and Financial Condition.

On August 12, 2021, Atea Pharmaceuticals, Inc. (the "Company") issued a press release announcing financial results for the three and six months ended June 30, 2021 and other matters described in the press release. A copy of the Company's press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.

The information disclosed under this Item 2.02, including Exhibit 99.1 hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, except as expressly set forth in such filing.

Item 9.01 Financial Statements and Exhibits.




(d) Exhibits.



               Exhibit
                 No.     Description

               99.1        Press release, dated August 12, 2021.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses